Screening and Access to Health Care for Vascular Disease

September 25, 2023 updated by: NorthShore University HealthSystem

Screening and Access to Health Care for Vascular Disease in Urban and Suburban Patient Populations

This is a pilot study designed to validate our methods of recruitment, screening and data collection in the community. The project will help to establish the feasibility of the study design to lay the groundwork for a potentially larger study. The final study will allow us to estimate the incidence and prevalence of abdominal aortic aneurysm (AAA), carotid artery stenosis, and peripheral artery disease (PAD) in different geographic areas in a large urban setting, as well as determine patient access to healthcare and treatment for vascular disease as related to geographic and racial differences.

Study Overview

Study Type

Observational

Enrollment (Actual)

190

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Illinois
      • Evanston, Illinois, United States, 60201
        • NorthShore University Healthsystem

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

55 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Volunteer subjects age 55 and over who sign informed consent will be enrolled in three separate neighborhoods in the Chicago area (North, South, West).

Description

Inclusion Criteria:

  • age 55 or older
  • willing/able to provide consent
  • willing to participate in follow-up phone calls at defined intervals for up to 5 years

Exclusion Criteria:

  • unable to provide consent to participate
  • unwilling/unable to participate in the follow-up phone call

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Geographic and racial differences in access to follow-up care if significant disease is identified through the screening event
Time Frame: 5 years
5 years

Secondary Outcome Measures

Outcome Measure
Time Frame
Geographical and racial differences in patterns of accessing healthcare prior to the screening events.
Time Frame: 1 year
1 year
Differences in rates of interventions throughout the 5 year follow-up period.
Time Frame: 5 years
5 years
Differences in the rates of complications related to treatment of vascular disease in the various geographic areas in which the events are held.
Time Frame: 5 years
5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Omar Morcos, MD, NorthShore University Healthsystem

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2014

Primary Completion (Actual)

May 1, 2021

Study Completion (Actual)

May 1, 2021

Study Registration Dates

First Submitted

June 26, 2013

First Submitted That Met QC Criteria

June 27, 2013

First Posted (Estimated)

June 28, 2013

Study Record Updates

Last Update Posted (Actual)

September 28, 2023

Last Update Submitted That Met QC Criteria

September 25, 2023

Last Verified

June 1, 2023

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Peripheral Arterial Disease

3
Subscribe